Consulting Services
The Consulting Services offered by Wells Therapeutics Inc. are designed to help partners navigate the "Value vs. Risk" landscape of the Chinese clinical market. These services aim to transform China’s operational advantages—such as 30–40% lower costs and access to large, treatment-naïve patient populations—into successful clinical outcomes by addressing local challenges like regulatory complexity and oversight
Expert Selection of CROs
Wells meticulously identifies and partners with mid-sized Contract Research Organizations (CROs) in China. They focus on finding the "perfect fit" for the specific objectives of U.S. biotech firms
On-the-ground Management
The company provides essential on-site support and project management. This facilitates seamless communication and coordination between sponsors, CROs, clinical sites, and various vendors.
Interested in learning more about our comprehensive services?
Trial-Type Determination
Wells uses its expertise to advise whether a study should be classified as an Investigator-Initiated Trial (IIT) or a Registrational Trial, which helps remove the "uncertainty and opaqueness" often associated with conducting trials in China
Regulatory Navigation
Wells meticulously identifies and partners with mid-sized Contract Research Organizations (CROs) in China. They focus on finding the "perfect fit" for the specific objectives of U.S. biotech firms